In Silico Targeting and Immunological Profiling of PpiA in Mycobacterium tuberculosis: A Computational Approach
Pathogens,
Journal Year:
2025,
Volume and Issue:
14(4), P. 370 - 370
Published: April 9, 2025
Tuberculosis
(TB)
remains
a
leading
cause
of
mortality,
with
drug
resistance
highlighting
the
need
for
new
vaccine
targets.
Peptidyl-prolyl
isomerase
A
(PpiA),
conserved
Mycobacterium
tuberculosis
(Mtb)
protein,
plays
role
in
bacterial
stress
adaptation
and
immune
evasion,
making
it
potential
target
immunotherapy.
This
study
uses
computational
methods
to
assess
PpiA's
antigenicity,
structural
integrity,
immunogenic
potential.
The
PpiA
sequence
was
retrieved
from
NCBI
analyzed
antigenicity
allergenicity
using
VaxiJen,
AllerTOP,
AllergenFP.
Physicochemical
properties
were
evaluated
ProtParam,
models
generated
through
PSIPRED
SWISS-MODEL.
Structural
validation
performed
MolProbity,
QMEANDisCo,
ProSA-Web.
B-cell
epitopes
predicted
BepiPred
2.0
IEDB,
while
T-cell
mapped
via
IEDB's
MHC-I
MHC-II
tools.
Epitope
conservation
across
Mtb
strains
confirmed
ConSurf.
Results
indicate
is
highly
antigenic,
non-allergenic,
stable,
several
identified
both
B-
T-cells.
supports
as
promising
TB
development.
Language: Английский
Redox Imbalance in Inflammation: The Interplay of Oxidative and Reductive Stress
Antioxidants,
Journal Year:
2025,
Volume and Issue:
14(6), P. 656 - 656
Published: May 29, 2025
Redox
imbalance
plays
a
pivotal
role
in
the
regulation
of
inflammation,
influencing
both
onset
and
progression
various
inflammatory
conditions.
While
pro-inflammatory
oxidative
stress
(OS)
is
well
established,
impact
reductive
(RS)—a
condition
marked
by
excessive
reducing
equivalents
such
as
NADH,
NADPH,
reduced
glutathione
(GSH)—remains
underappreciated.
This
review
offers
novel
integrative
perspective
analyzing
how
OS
RS
act
not
merely
opposition,
but
interconnected
modulators
immune
function.
We
explore
mechanisms
through
which
activates
pathways,
RS,
when
sustained,
can
paradoxically
impair
defense,
alter
redox-sensitive
signaling,
contribute
to
disease
progression.
Emphasis
placed
on
dynamic
interplay
between
these
redox
extremes
their
combined
contribution
pathogenesis
chronic
diseases,
including
autoimmune,
cardiovascular,
neuroinflammatory
disorders.
Additionally,
we
evaluate
therapeutic
strategies
that
target
homeostasis,
arguing
for
shift
from
antioxidant-centric
treatments
approaches
consider
bidirectional
nature
dysregulation.
framework
may
inform
development
more
precise
interventions
inflammation-related
diseases.
Language: Английский